This result implicates MTCP1 as a factor with considerable influence on the CLL disease course; yet it may not act as the fundamental driving element, which is not entirely surprising considering the abundance of evidence conferring the significant relationship between CLL outcomes and these other high-risk factors. This evidence concerns the gene MTCP1 and B-cell chronic lymphocytic leukemia.